Position
Creative Planning in Cytokinetics Inc
Back to the book · All holders of CYTK
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $229.8K$63.54 → $65.91
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 96.9K | $6.16M | — | — | — | 0.0% |
| Q1 2026 | 107.8K | $7.1M | $65.91 | $229.8K | $713.2K | 0.0% |